Visiomed Group SA (ALVMG) | Stock Overview & Key Data
Visiomed Group SA Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €173.86 on December 15, 2014
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Visiomed Group SA ALVMG | 53.17M Small_cap | 0.00% | 0.00% | 5.88% | 0.00% | 5.88% | 5.88% | -5.26% | -83.78% |
| Amplitude Surgical AMPLI | 295.02M Mid-cap | 0.00% | 0.00% | 1.67% | 91.82% | 90.63% | 82.63% | 110.34% | 293.55% |
| Crossject S.A ALCJ | 80.53M Small-cap | 15.69% | -2.75% | 77.00% | -14.90% | -20.98% | 0.59% | -47.20% | -51.70% |
| Bonyf N.V MLBON | 8.18M Small-cap | -7.19% | -14.57% | -27.53% | -30.27% | -28.33% | -16.77% | 7.50% | 3.20% |
| Spineway S.A ALSPW | 3.87M Small-cap | 8.33% | -7.14% | 30.00% | 44.44% | 44.44% | 0.00% | 0.00% | 0.00% |
| I.Ceram S.A ALICR | 155.73K Small_cap | 0.00% | 0.00% | 0.00% | -11.11% | 0.00% | -43.66% | -97.21% | -98.25% |
Ownership & Short Interest
Visiomed Group SA Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Visiomed Group SA would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
In the last 52 weeks, Visiomed Group SA reached a high of €0.25 (on September 24, 2024) and a low of €0.15 (on December 16, 2024).
Curious about Visiomed Group SA's size and valuation? Its market capitalization stands at 53.17M. When it comes to valuation, the P/E ratio (trailing twelve months) is 57.80, and the forward P/E (looking ahead) is 5.75.
As for dividends, Visiomed Group SA isn't currently offering a significant yield, or that specific data isn't available right now.
When looking at Visiomed Group SA, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Amplitude Surgical
AMPLI295.02M Healthcare Medical Instruments & Supplies 82.63% 110.34% Crossject S.A
ALCJ80.53M Healthcare Medical Instruments & Supplies 0.59% -47.20% Bonyf N.V
MLBON8.18M Healthcare Medical Instruments & Supplies -16.77% 7.50% Spineway S.A
ALSPW3.87M Healthcare Medical Instruments & Supplies 0.00% 0.00% I.Ceram S.A
ALICR155.73K Healthcare Medical Instruments & Supplies -43.66% -97.21% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
To get a sense of Visiomed Group SA's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.68%, the Debt to Equity ratio from the most recent quarter is 32.03, and its Gross Profit Margin stands at N/A.
Looking at Visiomed Group SA's growth, its revenue over the trailing twelve months (TTM) was €14M. Compared to the same quarter last year (YoY), quarterly revenue grew by 29.30%, and quarterly earnings saw a YoY growth of N/A.
Wondering who owns Visiomed Group SA stock? Company insiders (like executives and directors) hold about 0.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 2.01%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.